Search Count: 42
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: NUB, MES |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-5-(1-((1-Acetylpiperidin-3-Yl)Methyl)-5-Bromo-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: EDO, MES, I0U |
 |
N-Terminal Bromodomain Of Human Brd4 With (S)-5-(1-((1-(1-Isopropylpiperidine-4-Carbonyl)Piperidin-3-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: I0Z |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-3-Methyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, P4M, MES |
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-7-((R)-1,2-Dihydroxyethyl)-1,3-Dimethyl-5-(1-Methyl-1H-Pyrazol-4-Yl)-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, 7PE, P4X |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P0U |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P3R |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-((S)-Hydroxy(Phenyl)Methyl)-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULK |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N4-Cyclopropyl-N2-Methyl-6-(1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: ULE, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-6-((S)-Methoxy(Phenyl)Methyl)-N2-Methylpyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULQ |